Arkolith/Insider Trading/PHAT/Form 4

Breedlove Robert Charles

Principal Accounting OfficerPhathom Pharmaceuticals, Inc. (PHAT) · full profile →Form 4 · filed Jul 18, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$14K
Net Open-Market Flow
-$14K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 16, 2025Sell(S)2K$8.36$14K48K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-096917) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML